1 – 10 of 341
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
(
- Contribution to journal › Article
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
(
- Contribution to journal › Article
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Deep learning performance on MRI prostate gland segmentation : evaluation of two commercially available algorithms compared with an expert radiologist
(
- Contribution to journal › Article
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Systematic Augmentation in HSV Space for Semantic Segmentation of Prostate Biopsies
2023) 22nd Scandinavian Conference on Image Analysis, SCIA 2023 In Lecture Notes in Computer Science 13886. p.293-308(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Re : Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial